Skip to content
healthcare.dev

Amitiza

NDC 23635-508, lubiprostone, capsule, gelatin coated, from SpecGx LLC.

Product NDC
23635-508
Status
Listed
Labeler
SpecGx LLC
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021908
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/23635-508 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUBIPROSTONE8 ug/1

Pharmacologic classes

Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]

Package NDCNDC-11Package
23635-508-602363505086060 CAPSULE, GELATIN COATED in 1 BOTTLE (23635-508-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/164a2b47-0a52-4bb4-9e71-5342c2e951f4
  • NADAC price for package 23635050860

    GET /v1/drugs/nadac/23635050860

Use it

Look up 23635-508 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/23635-508 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 23635-508. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.